Search - tctmd.com

Displaying 121 - 138 of 138

Sort: Relevancy | Date

Presentation TVT 2015

Incidence and Prognostic Impact of Conduction Disturbances and Arrhythmias (AF) After TAVR

Presenter: Josep Rodés-Cabau

June 05, 2015

News Industry News

Medtronic CoreValve® Evolut(TM) R System Yields Exceptional Outcomes in First Clinical Study

March 16, 2015

Presentation TCT 2014

Conduction Disturbances (New LBBB and Pacemakers) After TAVR: Frequency, Clinical Impact, and Management Considerations

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib, Tamim Nazif

September 14, 2014

News Daily News

Patient Traits Predict Need for Permanent Pacemaker After TAVR

Yael L. Maxwell

July 10, 2014

News Daily News

A-fib, Dialysis Dramatically Worsen Outlook for TAVR Patients with Advanced CKD

May 07, 2014

News Daily News

TAVR-Linked Conduction Abnormality Worsens Functional Status, but Not Mortality

Jason Kahn

January 16, 2014

Presentation TCTAP 2013

Can We Prevent Conduction Disturbances?

Presenter: Corrado Tamburino

April 25, 2013

News Conference News TCT 2012

Review of TAVR Use Offers Significant Advances, Positive Outcomes

October 22, 2012

News Daily News

Persistent Left Bundle Branch Block after TAVR Linked to Ventricular Dysfunction

October 04, 2012

News Daily News

Tras Implantar la Válvula Sapien No suele hacerse Necesario un Marcapasos Permanente

L.A. McKeown

July 18, 2012

News Daily News

Need for Permanent Pacemaker Uncommon After Sapien Valve Implantation

L.A. McKeown

July 18, 2012

Presentation

Frequency of Conduction Disturbances after Edwards SAPIEN Percutaneous Valve Implantation

Presenter: A. Laynez

July 17, 2012

News Daily News

Repositionable Valve Yields Promising 2-Year TAVR Results

December 06, 2011

News Conference News

Study Focuses on Permanent Pacemaker Predictors in TAVI vs. Surgery

Jason Kahn

April 05, 2011

Video

» Live Case

LIVE CASE #9 Cardiac Conduction Disturbances and TAVR

July 28, 2021

Partner Content

Innovations in Temporary Pacing: The Tempo Lead (BioTrace Medical)

April 15, 2021

Video

» Topical Discussion

Implantation Considerations to Minimize Conduction Disturbances in TAVR: The Latin American Experience

February 1, 2021

Partner Content

Evolut™ Implant Strategies

December 30, 2020

Advertisement

Incidence and Prognostic Impact of Conduction Disturbances and Arrhythmias (AF) After TAVR

Medtronic CoreValve® Evolut(TM) R System Yields Exceptional Outcomes in First Clinical Study

Conduction Disturbances (New LBBB and Pacemakers) After TAVR: Frequency, Clinical Impact, and Management Considerations

Patient Traits Predict Need for Permanent Pacemaker After TAVR

A-fib, Dialysis Dramatically Worsen Outlook for TAVR Patients with Advanced CKD

TAVR-Linked Conduction Abnormality Worsens Functional Status, but Not Mortality

Can We Prevent Conduction Disturbances?

Review of TAVR Use Offers Significant Advances, Positive Outcomes

Persistent Left Bundle Branch Block after TAVR Linked to Ventricular Dysfunction

Tras Implantar la Válvula Sapien No suele hacerse Necesario un Marcapasos Permanente

Need for Permanent Pacemaker Uncommon After Sapien Valve Implantation

Frequency of Conduction Disturbances after Edwards SAPIEN Percutaneous Valve Implantation

Repositionable Valve Yields Promising 2-Year TAVR Results

Study Focuses on Permanent Pacemaker Predictors in TAVI vs. Surgery

LIVE CASE #9 Cardiac Conduction Disturbances and TAVR

Innovations in Temporary Pacing: The Tempo Lead (BioTrace Medical)

Implantation Considerations to Minimize Conduction Disturbances in TAVR: The Latin American Experience

Evolut™ Implant Strategies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content